Photos


This photo provided by Food and Drug Administration shows Arena Pharmaceutical’s anti-obesity pill Belviq. The Food and Drug Administration has approved Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. The agency cleared the pill Wednesday for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol.

(AP Photo/Food and Drug Administration)

You must be logged in to post comments. Please log in here or click the comment box below for options.

comments powered by Disqus


Sections


Profile

Contact the Spokesman

Main switchboard:
(509) 459-5000
Customer service:
(509) 747-4422
Newsroom:
(509) 459-5400
(800) 789-0029
Back to Spokesman Mobile